TCL Archive CMF Studies Show Higher Recurrence for Post-Menopausal Patients – Caldwell November 12, 1976
TCL Archive Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says April 26, 1996
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions September 27, 1996
TCL Archive Upton Struggling To wrap Up Reorganization Of DCCR Before Next Week’s Meeting Of NCAB September 28, 1979
